Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714804 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion
A NA study, sponsored by SeaSpine.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01714804 is a NA study that has completed, run by SeaSpine. The registered enrollment target is 30 participants.
The verdict
NCT01714804, a NA study, has completed, sponsored by SeaSpine.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for instrumented lumbar spine fusion with a retrospective comparison to a historical patient cohort.
Interventions
- DEVICE Accell Evo3 Prospective Use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714804
The ClinicalTrials.gov registry entry for NCT01714804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SeaSpine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Accell Evo3 Prospective Use is the first listed.
NCT01714804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714804 about?
NCT01714804 is a clinical study titled "Efficacy and Safety of Integra Accell Evo3 DBM in Instrumented Lumbar Spine Fusion". The objective of this study is to prospectively evaluate the performance of Integra Accell Evo3 Demineralized Bone Matrix as an adjunct for instrumented lumbar spine fusion with a retrospective comparison to a historical patient cohort.
What is the current status of trial NCT01714804?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-08. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01714804?
The interventions under investigation include: Accell Evo3 Prospective Use (DEVICE).
Who is sponsoring clinical trial NCT01714804?
This trial is sponsored by SeaSpine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.